## **Core Concept**
Beta-blockers are used in the management of glaucoma to decrease intraocular pressure (IOP). They achieve this by reducing the production of aqueous humor in the eye. The primary mechanism involves blockade of beta-adrenergic receptors in the ciliary body.

## **Why the Correct Answer is Right**
The correct answer, **timolol**, works by blocking beta-1 and beta-2 adrenergic receptors. This blockade decreases the production of cyclic AMP (cAMP) in the ciliary body, which in turn reduces the production of aqueous humor. Lower aqueous humor production leads to a decrease in intraocular pressure, providing therapeutic benefit in glaucoma patients.

## **Why Each Wrong Option is Incorrect**
- **Option A:** ***Latanoprost*** is a prostaglandin analog, not a beta-blocker. It works by increasing the outflow of aqueous humor, not by reducing its production.
- **Option B:** ***Acetazolamide*** is a carbonic anhydrase inhibitor. It decreases intraocular pressure by reducing aqueous humor production but through a different mechanism involving inhibition of carbonic anhydrase in the ciliary body.
- **Option D:** ***Pilocarpine*** is a muscarinic receptor agonist (miotic). It decreases intraocular pressure by increasing the trabecular outflow of aqueous humor.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that beta-blockers like **timolol** are often used as first-line treatment for glaucoma due to their efficacy in lowering intraocular pressure and their relatively favorable side effect profile compared to other classes of glaucoma medications.

## **Correct Answer:** . **timolol**